Strados Labs is at the forefront of respiratory health monitoring with its innovative RESP® Biosensor, recognized as the first FDA-cleared wearable stethoscope that captures lung sounds like coughs and wheezes. This cutting-edge technology allows for continuous, real-time monitoring of respiratory symptoms, providing crucial data that enhances asthma management, chronic cough treatment, and research in pulmonology. With a commitment to improving patient outcomes from hospital to home, Strados Labs offers an end-to-end solution that includes a wearable device, a mobile app for data tracking, and secure cloud storage for comprehensive analysis of lung health.

Founded with a mission to transform respiratory care, Strados Labs has gained significant recognition in both healthcare and life sciences sectors. The company focuses on leveraging accurate and validated data to support clinical trials and patient treatments. Its technology has captured over 600,000 validated coughs and 19 million breaths across four continents in 35 languages. Alongside its groundbreaking products, Strados Labs emphasizes privacy through advanced encryption methods and aims to deliver user-friendly devices that integrate seamlessly into daily life while providing healthcare professionals with vital insights into patient conditions.